GRI Stock Analysis: Buy, Sell, or Hold?

GRI - GRI Bio, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.13
0.10 (4.93%) ▲
5d: -5.75%
30d: -16.47%
90d: -7.79%
HOLD
LOW Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 21, 2026 2d

Get Alerted When GRI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: GRI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: GRI is currently trading at $2.13, which is considered oversold relative to its 30-day fair value range of $2.20 to $2.47.

Technical Outlook: Technically, GRI is in a uptrend. Immediate support is located at $1.97, while resistance sits at $2.40. The stock is showing strong short-term momentum, up 4.9% recently.

Market Sentiment: GRI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $160.00 (+7781.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $2.20 - $2.47
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 63.2%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.9%)
  • BULLISH: Trading 7781.8% below Wall St target ($160.00)
  • CAUTION: Recommendation downgraded due to -5.8% 5-day decline

Trading Range Analysis

30-Day Trading Range $2.20 - $2.47
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $1.97
Resistance Level $2.40
Current Trend Uptrend
Technical data as of May 18, 2026

Fundamental Context

Forward P/E (Next Year Est.) -0.25
Wall Street Target $160.00 (+7781.8%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 18, 2026 2:47 PM ET
Data refreshes hourly during market hours. Next update: 3:47 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$411 53 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$126 55 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$83 57 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 52 HOLD

More Analysis for GRI

GRI Technical Chart GRI Price Prediction GRI Earnings Date GRI Investment Advisor GRI Fair Price Analyzer GRI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals